.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Covington
Queensland Health
Argus Health
McKesson
Daiichi Sankyo
Colorcon
Mallinckrodt
Chinese Patent Office
Cipla

Generated: September 20, 2017

DrugPatentWatch Database Preview

BRETHINE Drug Profile

« Back to Dashboard

Which patents cover Brethine, and when can generic versions of Brethine launch?

Brethine is a drug marketed by Ani Pharms Inc and Pharmacare and is included in two NDAs.

The generic ingredient in BRETHINE is terbutaline sulfate. There are seven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

Summary for Tradename: BRETHINE

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list27
Clinical Trials: see list2
Patent Applications: see list3,736
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BRETHINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
BRETHINE
terbutaline sulfate
TABLET;ORAL017849-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
BRETHINE
terbutaline sulfate
TABLET;ORAL017849-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Pharmacare
BRETHINE
terbutaline sulfate
INJECTABLE;INJECTION018571-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BRETHINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms Inc
BRETHINE
terbutaline sulfate
TABLET;ORAL017849-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pharmacare
BRETHINE
terbutaline sulfate
INJECTABLE;INJECTION018571-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ani Pharms Inc
BRETHINE
terbutaline sulfate
TABLET;ORAL017849-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ani Pharms Inc
BRETHINE
terbutaline sulfate
TABLET;ORAL017849-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ani Pharms Inc
BRETHINE
terbutaline sulfate
TABLET;ORAL017849-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pharmacare
BRETHINE
terbutaline sulfate
INJECTABLE;INJECTION018571-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cerilliant
Chubb
Cantor Fitzgerald
Daiichi Sankyo
Accenture
Julphar
Dow
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot